This inventor holds 3 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 1984-1987.
Company Filing History:
Years Active: 1984-1987
Title: Walter Wesenberg: Innovator in Pharmaceutical Chemistry
Introduction
Walter Wesenberg is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, Wesenberg's work is recognized for its potential impact on drug development and agricultural protection.
Latest Patents
Wesenberg's latest patents include innovative compounds such as Azolylmethylcycloalkanes and Azolylmethylcycloacetals. The first patent describes Azolylmethylcycloalkanes of the formula I, where various substituents can be present, making these compounds useful for treating disorders and for crop, wood, and material protection. The second patent focuses on Azolylmethylcycloacetals, which exhibit antimycotic action and are described with specific structural formulas. These compounds are also noted for their physiologically tolerated addition salts with acids.
Career Highlights
Walter Wesenberg is associated with BASF Aktiengesellschaft, a leading company in the chemical industry. His work at BASF has allowed him to explore and develop innovative solutions in pharmaceutical chemistry. His contributions have been instrumental in advancing the understanding and application of new chemical compounds.
Collaborations
Wesenberg has collaborated with esteemed colleagues such as Friedrich-Wilhelm Kohlmann and Wolfgang Heberle. These collaborations have fostered a productive environment for research and innovation, leading to the development of impactful patents.
Conclusion
Walter Wesenberg's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and agricultural protection.
